Track topics on Twitter Track topics that are important to you
Metabolic-focused start-up Azafaros BV raised €25M ($28M) through its Series A financing led by Forbion, which was joined by BioMedPartners and BioGeneration Ventures. Representatives from each inve...
A Series A funding round produced $27.5 million for Azafaros, which is focused on developing its pipeline for rare metabolic -More-
This round was led by Forbion, with participation from BioMedPartners and founding investor BioGeneration Ventures (BGV). Azafaros was established in 2018 to translate innovative science from Leiden U...
Financing round led by Forbion with participation from BioMedPartners and founding investor BioGeneration Ventures Azafaros B.V. announced today the successful closing of its Series A financing r...
Azafaros was founded in 2018 by a team of experienced industry professionals and scientists aspiring to address rare genetic metabolic disorders through a pipeline of oral small molecules with diseas...
We have published hundreds of Azafaros B.V. news stories on BioPortfolio along with dozens of Azafaros B.V. Clinical Trials and PubMed Articles about Azafaros B.V. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Azafaros B.V. Companies in our database. You can also find out about relevant Azafaros B.V. Drugs and Medications on this site too.
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...